Liang Ma, PhD, assistant professor at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and the Department of Pharmacology, and Agustin Ruiz, MD, professor and director of the Biggs Institute’s Biological Core laboratory, were both quoted in this article. Read More
Share This Story
A study by UT Health San Antonio about Alzheimer’s disease risk across populations was mentioned in this news segment. Watch Now
Share This Story
Advancement in the detection and treatment of Alzheimer’s and other neurodegenerative diseases means more people can preserve brain health for longer. But a crisis looms as an onslaught of people at risk for neurodegenerative diseases in the next 40 years is met with a shortage of health care providers. According to the U.S. […]
Share This Story
Neela K. Patel, MD, chief, Division of Geriatrics and Supportive Care, Department of Family and Community Medicine, and outreach recruitment and engagement director at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Sudha Seshadri, MD, Department of Neurology, founding director of the Biggs Institute, was mentioned in this article. […]
Share This Story
In the coming years, Africa is expected to sustain the greatest increase in Alzheimer’s and related dementia cases. Advancing the ability of African scientists to conduct research in these fields is critical for progress in understanding and treating these conditions. A transformative training program crafted through a collaboration between the Glenn Biggs Institute for Alzheimer’s […]
Share This Story
Late-onset Alzheimer’s disease is a debilitating, progressive neurodegenerative disease that affects about 7 million Americans, a figure that is expected to nearly double by 2050, according to the Alzheimer’s Association. While there is no cure for the disease, early detection and treatment can preserve brain function for longer. A study by researchers at The University […]
Share This Story